Recro Pharma announces five-year manufacturing and supply agreement with Novartis
Recro Pharma announced that Recro Gainesville, its CDMO division, has entered into a five-year manufacturing and supply agreement with Novartis Pharma. Recro Gainesville will continue to be the exclusive global supplier to Novartis of Ritalin LA and Focalin XR capsules through 2023. February 11, 2019